Simplex Trading
MIST icon

Simplex Trading’s Milestone Pharmaceuticals MIST Stock Holding History

Simplex Trading’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Sell
8,300
-71,400
-90% -$114K ﹤0.01% 7606
2026
Q1 		$94.8K Buy
+79,700
New +$140K ﹤0.01% 5149
2025
Q4 		– Sell
-36,200
Closed -$72K – 9463
2025
Q3 		$72K Buy
36,200
+29,200
+417% +$51.3K ﹤0.01% 6100
2025
Q2 		$13K Sell
7,000
-3,000
-30% -$4K ﹤0.01% 7116
2025
Q1 		$8K Buy
10,000
+5,900
+144% +$11.7K ﹤0.01% 7247
2024
Q4 		$9K Buy
+4,100
New +$7.04K ﹤0.01% 7269
2024
Q1 		– Sell
-2,500
Closed -$4K – 9444
2023
Q4 		$4K Buy
+2,500
New +$6.79K ﹤0.01% 7982
2022
Q4 		– Sell
-183,200
Closed -$1.68M – 9918
2022
Q3 		$1.68M Buy
+183,200
New +$1.39M ﹤0.01% 2111
2021
Q4 		– Sell
-31,000
Closed -$174K – 11026
2021
Q3 		$174K Hold
31,000
– – ﹤0.01% 5818
2021
Q2 		$170K Buy
31,000
+30,839
+19,155% +$175K ﹤0.01% 5950
2021
Q1 		$93K Buy
+161
New +$1.18K ﹤0.01% 5853
2020
Q4 		– Sell
-500
Closed -$366K – 8793
2020
Q3 		$366K Buy
+500
New +$3.58K ﹤0.01% 3377

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Simplex Trading's MIST Position: Q2 2026 in Review

Simplex Trading reduced its Milestone Pharmaceuticals (MIST) stake by 64% in Q2 2026, selling an estimated $152K and leaving 54,171 shares worth $72.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5919.

Simplex Trading first reported a position in MIST in Q3 2020 and has held it in 11 quarters since. The position peaked at $178K in Q1 2026. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Simplex Trading held 54,171 shares of Milestone Pharmaceuticals worth $72.6K as of Q2 2026.
  • Simplex Trading sold 95,120 Milestone Pharmaceuticals shares in Q2 2026, an estimated $152K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5919 holding.
  • Simplex Trading first reported a position in Milestone Pharmaceuticals in Q3 2020 and has held it in 11 quarters since.
  • Simplex Trading's Milestone Pharmaceuticals position peaked at $178K in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.